JACQUELINE ROSS: Open Payments
NPI 1578118048 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$197 in 9 payments from 7 companies in 2025. Trend: 2023 $240 · 2024 $891 · 2025 $197
Food & beverage: $197
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Novo Nordisk Inc | 2 | $46 |
| Lilly USA, LLC | 1 | $30 |
| PFIZER INC. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Amgen Inc. | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: REXULTI, Rybelsus, JARDIANCE, AIRSUPRA, Ozempic, OTEZLA, XIFAXAN.
Industry payments across GA — which companies pay providers there.
